Channel Therapeutics Corporation (CHRO)
Jul 2, 2025 - CHRO was delisted (reason: merged into PTHS)
13.50
0.00 (0.00%)
Inactive · Last trade price on Jul 1, 2025

Company Description

Channel Therapeutics Corporation, a clinical-stage biotech company, develops and commercializes new therapeutics to alleviate pain.

It targets sodium ion-channel NaV1.7; and develops NaV blockers that target the body’s peripheral nervous system.

The company’s lead compound is CC8464, which has completed Phase 1 clinical trials for the treatment of moderate-to-severe pain in erythromelalgia and idiopathic small fiber neuropathy.

It also develops CT2000 as a topical agent for the treatment of both acute and chronic eye pain; and CT3000 to treat post operative pain with the use of nerve blocks.

The company was Chromocell Therapeutics Corporation and changed its name to Channel Therapeutics Corporation in November 2024.

Channel Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Channel Therapeutics Corporation
Channel Therapeutics logo
CountryUnited States
Founded2002
IPO DateFeb 16, 2024
IndustryBiotechnology
SectorHealthcare
Employees11
CEOFrancis Knuettel

Contact Details

Address:
4400 Route 9 South, Suite 1000
Freehold, New Jersey 07728
United States
Phone877 265 8266
Websitechanneltherapeutics.com

Stock Details

Ticker SymbolCHRO
ExchangeNYSEAMERICAN
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$6.00
CIK Code0001919246
CUSIP Number171126105
ISIN NumberUS1711261057
Employer ID86-3335449
SIC Code2836

Key Executives

NamePosition
Francis Knuettel II, M.B.A.President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Director
Dr. Eric Lang M.D.Chief Medical Officer

Latest SEC Filings

DateTypeTitle
Jul 2, 20258-KCurrent Report
May 27, 2025DEFM14CFiling
May 13, 202510-QQuarterly Report
May 9, 2025PREM14CFiling
May 1, 20258-KCurrent Report
Apr 17, 20258-KCurrent Report
Mar 27, 202510-KAnnual Report
Mar 3, 20258-KCurrent Report
Feb 14, 2025SCHEDULE 13GFiling
Jan 15, 2025SCHEDULE 13GFiling